Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hepion Pharmaceuticals, Inc.

0.0560
+0.013732.53%
Post-market: 0.0500-0.0060-10.71%16:00 EDT
Volume:4.74M
Turnover:407.89K
Market Cap:614.62K
PE:0.00
High:0.2500
Open:0.0439
Low:0.0404
Close:0.0423
Loading ...
Jan 14, 2025

Correspondence

Form CORRESP - Correspondence
Jan 14, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 13, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Dec 26, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Nov 21, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 05, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Sep 05, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Jul 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 22, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 12, 2024

Correspondence

Form CORRESP - Correspondence
Jul 11, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 25, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
May 21, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]